Ms. Rebecca Holland New is Senior Vice President Human Resources of Patheon Inc., since August 2011. Most recently, from November 2007 to July 2011, Ms. Holland New was Global Vice President, Human Resources at Bausch & Lomb, Inc. Prior to that, from April 2007 to October 2007, Ms. Holland New held global human resources leadership positions at Bausch & Lomb?s business operations, talent, corporate and pharmaceutical business units as well as global research and development. Prior to joining Bausch & Lomb, Ms. Holland New held human resources leadership positions at Novo Nordisk, Inc., from November 2003 to April 2007, and BristolMyers Squibb, from August 1996 to November 2003. Ms. Holland New is an Advisory Member for Cornell University?s Industrial and Labor Relations Professional Development Initiatives.
The company has return on total asset (ROA) of 3.86 % which means that it generated profit of $3.86 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of (85.87) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 589.6 M in total debt with debt to equity ratio (D/E) of 5.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Patheon Inc has Current Ratio of 1.69 which is within standard range for the sector.
Patheon Inc. offer drug development and manufacturing services to the pharmaceutical, biotechnology, and specialty pharmaceutical companies worldwide. Patheon Inc [PTI] is traded on Toronto Stock Exchange in Canada. It is located in Mississauga, ON LN K and employs 4,700 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory